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Background: Several noninvasive tests are available to risk stratify pts for sudden cardiac 
death but are limited by the need for a normal QRS duration for accurate interpretation. T- 
wave alternans (TWA) has been proposed as a noninvasive test that can be used in pts 
with left bundle branch block (LBBB). The purpose of this study was to compare and con- 
trast the sensitivity and specificity of TWA in pts with and without LBBB. 
Methods: We prospectively evaluated 154 pts (101 men, mean age 62 ± 23 yrs) referred 
for EPS. All pts underwent EPS using programmed stimulation at two ventricular sites with 
up to triple extrastimuli with and without isoproterenol or dobutamine. At the time of EPS, 
all pts underwent TWA testing during rapid atrial pacing with the Cambridge Heart CH2000 
or HearTwave system. TWA was interpreted according to standard protocol. Indeterminate 
tests were excluded from further analysis (31 pts, 20%). Positive EPS was defined as the 
induction of sustained monomorphic ventricular tachycardia with up to triple ventricular 
extrastimuli or ventricular fibrillation with up to double ventdcular extrastimuli. 
Results: 16 pts (13%) had LBBB on ECG and 107 pts (87%) had a normal QRS duration. 
There was no difference between the two groups with regard to gender, age, indication for 
EPS, presence of CAD, or use of beta blockers, However, LBBB was associated with a 
lower LVEF (28% ±8 vs. 40% ±15, p<0.001 ). 6 pts (38%) with LBBB and 34 pts (32%) with 
a normal QRS had positive EPS (p=0.78). In comparison, the positivity rate of TWA was 
81% in pts with LBBB vs. 43% in pts with a normal QRS (p=0.006). The sensitivity of TWA 
for predicting inducibility at EPS was 83% in pts with LBBB and 47% in pts without LBBB 
(p=0.19). However, the specificity was only 20% in the pts with LBBB compared with 59% 
in the pts with normal QRS (p=0.04). 
Concluelons: The presence of a LBBB on ECG was associated with a trend towards 
increased sensitivity, but also a marked reduction in specificity of TWA for predicting induc- 
ibility at EPS. This should be considered when interpreting the results of TWA in pts with 
LBBB. 
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Background: Based on the results of MADIT and MUSTT, patients (pts) with coronary 
artery disease (CAD), depressed LV function and non-sustained ventricuier techycardie 
(NSVT) who have inducible VT at electrophysiologic (EP) testing benefit from an ICD. 
However, in these prior studies, isoproterenol (ISO) was not given to facilitate induction 
of VT in non-inducible pts. Therefore, we sought to determine the incremental yield of 
ISO in non-inducible pts and to evaluate their long-term outcome. 
Methods: We evaluated consecutive pts with CAD, LVEF < 40% and NSVT who under- 
went EP testing between 1997-2000. Programmed stimulation was performed with up to 
3 ventricular extrastimuli (VES) from 2 right ventricular (RV) sites; in pts in whom sus- 
tained V'F was not inducible, repeat EP testing with up to 3 VES from 1 RV site during 
infusion of ISO (titratad to increase the heart rate by 20% from baseline) was performed. 
Patients with inducible sustained VT received an ICD and were followed every 3-6 
months in our ICD clinic. 
Results: EP testing was performed in 238 patients (194 M, LVEF 29 -+ 8%, 11 + 8 beats 
Nsv'r with a cycle length of 373 ± 69 ms). Sustained VT was inducible at baseline in 103 
(43%) pts. Of the 135 (57%) pts who were non-inducible, 40 (30%) did not undergo 
repeat EP testing during ISO infusion, most commonly because VF had been induced 
with 3 VES in these patients during EP testing in the baseline state. The remaining 95 
(70%) non-inducible pts underwent repeat testing during ISO infusion; sustained V'I" was 
inducible in 8/95 (8%) pts. One of these 8 pts died peri-ICD implant from non-cardiac 
complications. The remaining 7 pts were followed for 31 _+ 18 months during which time 
2./7 (29%) of these pts received an appropriate ICD therapy for monomorphic VT. 
Conclusions: tn pts with CAD, LVEF -< 40% and NSVT who undergo EP testing for risk 
stratification, 8% of non-inducible pts have inducible VT during ISO infusion, which 
appears to be of prognostic significance. 
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Background: Studies have emphasized specific associations between genotype and 
symptoms (sx) in Long QT Syndrome (LQTS) patients (pts). Methods: We studied 60 sx, 
genotyped LQTS pts (20 LQT1, 31 LQT2, 9 LQT3) from 28 genetically distinct families 
using direct interviews with pt and/or family members regarding 103 episodes of syn- 
cope, aborted cardiac arrest, or sudden death. All data were cress-referenced with physi- 
cian and medical charts. Fifty-one pts (80%) were female with average age at 
presentation of 22 _+ 13 yrs. Multiple sx were manifest in 33/64 pts (52%), range = 2-5 per 
pt. Sx (103 episodes) were classified as during exercise (n=29, 28%), emotional upset 
(n=14; startle (4), anger (6), pain (1), and severe psychosocial distress (3); 14%), audi- 
tory stimulus (n=8, 8%), with sleep (10, 10%), and with no provocative stimulus (NPS) 
(n=42, 41%). Results: No provocative stimulus was a trigger more commonly in LQT2 
pts (p < 0.0001 ). Exercise as a trigger was more commonly seen in LQT1 Lots (p < 0.001), 
while sleeping stimuli were more frequently seen in LQ'f'3 pts (p < 0.01). In 33 pts with 
multiple events, 3/7 LQT1 pts (43%) had sx in the same category over time, as compared 
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with 9./20 LQT2 pts (45%) and 0/5 LQT3 pts (0%) (NS). Conclusions: (1) No obvious 
trigger was found for sx in many LQTS pts, especially for LQT2 pts. (2) Exercise was a 
more common trigger in LQT1 pts, while sleeping-associatdd stimuli were seen more fre- 
quently in LQT2 and LQT3 pts. (3) A given symptom complex was a poor predictor of 
subsequent similar symptoms. 
Cardiac symptoms In 60 pts by genotype (n=103 episodes) 
LQT1 LQT2 LQT3 
Exercise (n=29) 20/29 (69%) 5/29 (17%) 4/29 (14%) 
Emotion (n=14) 6/14 (43%) 7/14 (50%) 1/14 (7%) 
Auditory (n=8) 2/6 (25%) 5/6 (63%) 1/8 (13%) 
Sleep (net0) 0/10 (0%) 6/10 (60%) 4/10 (40%) 
NPS (n=42) 5/42 (12%) 32/42 (76%) 5/42 (12%) 
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Background: Electrophysiologic (EP) testing is used to stratify patients with coronary 
artery disease (CAD), depressed ejection fraction (EF), and non-sustained ventricular 
tachycardia (vr) for risk of clinical arrhythmic events. However, even those patients with a 
negative test have a high risk of cardiac arrest, as confirmed by the MUSTT registry. We 
hypothesized that intravenous precainamide (PA) in patients with a negative EP study in 
the baseline state (BS) would identify additional patients with the substrete for re-entrant 
VT who are at increased risk for sudden death. 
Methods: Using the Yale EP database we identified 58 consecutive patients with CAD, 
depressed El:, and non-sustained VT who underwent EP testing for risk assessment, who 
received a 3 rd generation ICD (Guidant) between 11/92 and 5/00, and for whom >2 months 
f/u was available. Mean f/u was 22 +/- 18 months. ICD records including intra-cerdiec elec- 
trograms and event details were reviewed to determine the occurrence of ventdcular 
arrhythmias resulting in ICD therapy. 
Results: 39 patients were inducible in the BS and 19 were inducible only following intrave- 
nous PA. This increased the yield of EP risk assessment by 49%. There was no difference 
in age, sex, beta-blocker use, anti-arrhythmic treatment, El:, or f/u time between the two 
groups. Ventricuier arrhythmias resulting in tCD therapy occurred in 14 patients inducible in 
the BS and in 7 patients inducible only with intravenous PA. Positive predictive values of 
EP testing in the BS and with PA were 36% and 37% (pens). There was no difference in 
survival between the two groups. 
Conclusion: The provocative use of intravenous PA dudng EP risk assessment increases 
the detection rate for risk of sudden death with no loss of positive predictive value. 
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Background: Unlike hypertherrnio injury, cryothermal tissue injury preserves underlying 
tissue architecture and associated thrombus formation is less likely. These characteris- 
tics may be beneficial in pulmonary vein (PV) ablation. We thus investigated the safety 
and feasibility of PV isolation using a percutaneous 7F cryoablation system in patients 
with atda( fibdllation (AF). 
Methods: We performed 23 consecutive PV cryoablation procedures in 20 Lots (16 M, 
age 55.5+/-9.7 yrs) with paroxysmal AF (15), persistent AF (4) and atrial tachyoardia (1). 
Pre-ablation transesophageal echocardiography was performed to assess PV anatomy 
and to exclude the presence of left atrial (LA) thrembus. After trans-septal puncture each 
target PV was mapped near its ostium, with a circumferential "Lasso" catheter. After DC 
cardioversion when required, cryoabietive lesions (-75°C for < 4rain) were applied to 
each LA-PV connection, proximal to the Lasso during sinus rhythm or coronary sinus 
pacing using a Cryocath "Freezor" catheter. PV isolation was defined as either the disso- 
ciation of PV from LA electrograms or their elimination. Venograms of all target PVs were 
performed before and after ablation. 
Results: Twenty-nine PVs (diameters 1.7 +/- 0.4cm) were targeted. Eighteen (62%) of 
the treated PVs were completely isolated. In the other 11 (38%) there was prolongation 
of LA to PV conduction time, altered PV activation sequence and PV electrogram attenu- 
ation. Procedure and fluoroscopy times were 282 +/- 95 (165-560) and 61.1 +/- 30.8 (7,9- 
120) rain respectively. The number of cryoablation applications and the cryoablatien time 
per PV were 19 +/- 12.7 (2-52) and 63.6 +/- 38.4 (7-1573) rain respectively. There was 
no acute PV stenosis and no thromboembolic event. There was no late PV stenosis 102- 
121 days after cryoablation in all 4 cryothermy treated PVs of the 3 pts who returned for 
second procedures. 
Conclusion: Percutaneous cryoablation appears safe and effective for focal AF ablation. 
